Covid19 South America 

Chilean copper miners threaten strike over alarming increase in Covid-19 cases

SANTIAGO – Chilean copper miners’ unions called on Sunday for a re-evaluation of the operational continuity plans of the country’s biggest miners during what they said was an “alarming” increase in coronavirus cases among workers. In a statement signed by the union leadership of state-owned Codelco, the Mines Federation – which groups the majority of workers for Chile’s major copper mines – rejected the “business as usual” discourse advanced by miners and the mines minister, Baldo Prokurica. “The increase in cases is alarming and demonstrates that the preventive measures implemented…

Read More
Africa Mining 

Manganese Mining Halted in Luano

A group of illegal manganese miners in Chingola’s Luano area have been directed to halt operations until they obtain relevant documentation for mining activities. Chingola Mayor Titus Tembo who visited the site was in shock that some illegal manganese mining activities were taking place in Luano. He said the group had been directed to immediately stop operations and asked them to formalize their status. Mr Tembo disclosed that the group was working under a company called Mosco Mining whose trace remains unknown. He added that the group has since been…

Read More
Covid19 Europe 

Russia backing antiviral drug Avifavir for Covid-19 fight good news for India

Russia’s approval of the antiviral drug Avifavir to treat Covid-19 is good news for India as it is based on an influenza medication already in advanced clinical trials here, say scientists. Avifavir, described by its developers in Russia as perhaps the most promising anti Covid-19 drug in the world, is derived from Favipiravir. Mumbai-based Glenmark Pharmaceuticals announced last week that Favipiravir is under phase 3 clinical trials – the penultimate stage in drug testing in India. Stating that Avifavir has shown high efficacy in treating patients with coronavirus during clinical…

Read More
Asia Covid19 Europe 

Russia backing antiviral drug Avifavir for Covid-19 fight good news for India, say scientists

 Russia’s approval of the antiviral drug Avifavir to treat Covid-19 is good news for India as it is based on an influenza medication already in advanced clinical trials here, say scientists. Avifavir, described by its developers in Russia as perhaps the most promising anti Covid-19 drug in the world, is derived from Favipiravir. Mumbai-based Glenmark Pharmaceuticals announced last week that Favipiravir is under phase 3 clinical trials – the penultimate stage in drug testing – in India. Stating that Avifavir has shown high efficacy in treating patients with coronavirus during…

Read More

Russia approves drug to treat Covid-19, hospitals to use in June

RDIF has provided funding into Russia’s development and production of the drug which is based on favipiravir, an anti-influenza drug first developed in Japan under the name Avigan, in a 50-50 joint venture with Russian pharmaceutical firm ChemRar. “It’s a major, major step forward,” RDIF CEO Kirill Dmitriev told CNBC Monday. “We believe there are now only two antiviral drugs against the virus that are really effective, those are remdesivir, done by the U.S., and this favipiravir, which also has significant promise,” he told CNBC’s “Squawk Box Europe.” RDIF and…

Read More